Segulah pockets €175m on Medstop sale
The exit to pharmaceuticals group Oriola-KD is the first by the Swedish firm’s Fund IV, a 2008 vintage now 70% invested.
The exit to pharmaceuticals group Oriola-KD is the first by the Swedish firm’s Fund IV, a 2008 vintage now 70% invested.
Copyright PEI Media
Not for publication, email or dissemination